A phase 1, placebo-controlled, randomised, double-blind (within dose panels) study evaluating the safety, tolerability and pharmacokinetics of intravenous NXY-059 in Japanese subjects.

Saved in:
Bibliographic Details
Title: A phase 1, placebo-controlled, randomised, double-blind (within dose panels) study evaluating the safety, tolerability and pharmacokinetics of intravenous NXY-059 in Japanese subjects.
Authors: Watabe M (AUTHOR), Cheng YF (AUTHOR), Nilsson D (AUTHOR), Itoh Y (AUTHOR), Kumagai Y (AUTHOR)
Source: Current Medical Research & Opinion. Aug2007, Vol. 23 Issue 8, p1849-1857. 9p.
Database: Academic Search Ultimate
Description
ISSN:03007995
DOI:10.1185/030079907x210679